Core Viewpoint - Align Technology reported mixed financial results for Q2 2024, with adjusted earnings per share increasing but revenues missing estimates, leading to a cautious outlook for the remainder of the year [2][3][9]. Financial Performance - Adjusted earnings per share for Q2 2024 were $2.41, an increase of 8.6% year over year, surpassing the Zacks Consensus Estimate by 3.9% [2] - GAAP earnings per share decreased to $1.28, down 12.3% from the previous year [2] - Total revenues rose 2.6% year over year to $1.03 billion, but fell short of the Zacks Consensus Estimate by 0.9% [3] Segment Analysis - Revenues from the Clear Aligner segment decreased by 0.1% year over year to $831.7 million, impacted by a 1.7% unfavorable foreign exchange effect [4] - Imaging Systems & CAD/CAM Services revenues increased by 16.1% to $196.8 million, also affected by a 1.7% unfavorable currency impact [4] Margins and Expenses - Gross profit for Q2 was $722.6 million, up 1.3% year over year, but gross margin contracted by 95 basis points to 70.3% due to a 5.9% increase in the cost of net revenues [5] - SG&A expenses decreased by 0.2% to $452.3 million, while R&D expenses rose by 4.2% to $92.2 million [5] - Operating income increased by 3.6% to $178.2 million, with an operating margin expansion of 17 basis points to 17.3% [5] Cash Flow and Stock Repurchase - Cash and cash equivalents at the end of Q2 were $761.4 million, down from $865.8 million at the end of Q1 [6] - The company repurchased approximately 0.6 million shares for $150 million during the quarter, with $500 million remaining under its $1 billion stock repurchase program [7][8] Guidance - For full-year 2024, Align Technology expects revenue growth of 4-6%, revised down from 6-8%, with a Zacks Consensus Estimate of $4.12 billion [9] - The company anticipates a slight decline in GAAP operating margins compared to 2023, while non-GAAP operating margins are expected to be above 2023 levels [9] - For Q3 2024, revenue guidance is set between $0.9 billion and $1 billion, with a consensus estimate of $1.03 billion [9] Estimate Trends - Consensus estimates have trended downward, with a shift of -6.12% noted over the past month [10] VGM Scores - Align Technology currently holds a poor Growth Score of F, a Momentum Score of B, and a Value Score of D, placing it in the bottom 40% for the value investment strategy [11]

Dublin, Aug. 22, 2024 (GLOBE NEWSWIRE) -- The "Columbia Digital Dentistry Market Size, Share & Trends Analysis | 2024-2030 | MedSuite | Includes: Dental CAD/CAM Devices, Dental CAD/CAM Materials (Discs & Blocks), Dental 3D Printers, and 2 more" report has been added to ResearchAndMarkets.com's offering.In 2023, the Colombian digital dentistry market was valued at nearly $14.3 million. It is expected to grow at a CAGR of 3.8%, reaching over $18.6 million by the end of the forecast period. The comprehensive ...

Monty Rakusen/DigitalVision via Getty Images Introduction Align (NASDAQ:ALGN) recently released earnings and they were quite underwhelming. While Align is a quality company, the earnings growth is simply not enough. At the time of writing, Align is down 21.56% year-to-date and the stock dropped over 4% following the earnings report and continued to slide ever since... Data by YCharts So without further ado, let's take a look at the numbers and see if we can find a reason for this sell-off. The Numbers Align ...

Align Technology’s (ALGN) dental average selling prices (ASPs) are being severely impacted by the current economic uncertainty and foreign exchange headwinds. The competitive landscape also remains an overhang. The stock carries a Zacks Rank #4 (Sell) currently.The ongoing industry-wide trend of staffing shortages and supply chain-related hazards is denting Align Technology margins. Deteriorating international trade and global inflationary pressure are leading to a tough situation related to raw material an ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________ FORM 10-Q ____________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-32259 ____________________________ ALIGN TECHNOLOGY, INC. (Exact name ...

Align Technology, Inc. (ALGN) delivered second-quarter fiscal 2024 adjusted earnings per share (EPS) of $2.41, up 8.6% from the year-ago quarter’s level. The reported figure topped the Zacks Consensus Estimate by 3.9%.GAAP EPS for the quarter was $1.28 compared with $1.46 in the prior-year quarter. This reflected a decline of 12.3% year over year.RevenuesThe top line increased 2.6% year over year to $1.03 billion, but missed the Zacks Consensus Estimate by a marginal 0.9%. Revenues were unfavorably impacted ...

Financial Data and Key Metrics Changes - Total Q2 2024 revenues were $1,028.5 million, up 3.1% sequentially and 2.6% year-over-year, driven by growth in Clear Aligner volumes and Imaging Systems and CAD/CAM Services revenues [7][23] - Q2 2024 non-GAAP operating margin was 22.3%, up 2.5 points sequentially and 1.0 point year-over-year [9][32] - Q2 2024 net income per diluted share was $1.28, down sequentially $0.11 and down $0.18 year-over-year, while non-GAAP net income per diluted share was $2.41, up $0.27 sequentially and $0.19 year-over-year [34] Business Line Data and Key Metrics Changes - Clear Aligner revenues for Q2 2024 were $831.7 million, up 1.8% sequentially but flat year-over-year, impacted by lower ASPs and higher discounts [23][24] - Imaging Systems and CAD/CAM Services revenues increased 9.2% sequentially and 16.1% year-over-year, reflecting strong adoption of the iTero Lumina scanner [10][19] - Non-Case revenues, including Vivera retainers, were up 3.5% sequentially and 5.1% year-over-year, driven by growth in retainers and the Doctor Subscription Program [12] Market Data and Key Metrics Changes - Clear Aligner volumes increased 6.2% sequentially and 3.2% year-over-year, with strong growth from adult patients and teen case starts, particularly in Asia Pacific, EEMA, and Latin America [8][11] - The number of doctors submitting teen or younger patient case starts was up 8% year-over-year, indicating strong adoption in the teen segment [11] - The adoption of the my Invisalign consumer patient app increased, with over 4 million downloads and 384,000 monthly active users, reflecting a growing digital engagement [18] Company Strategy and Development Direction - The company continues to invest in consumer marketing and demand creation initiatives to raise awareness of Invisalign, with over 17 billion impressions globally [15][16] - The introduction of the iTero Design Suite aims to enhance practice efficiencies and patient experiences through 3D printing capabilities [21] - The company is focused on expanding its digital platform and enhancing the adoption of digital workflows in the dental industry, particularly through partnerships with Dental Service Organizations (DSOs) [14][39] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the stability of end markets despite unfavorable foreign exchange impacts, emphasizing the commitment to support doctor customers in digital innovation [38] - The company anticipates Q3 2024 revenues to be in the range of $980 million to $1 billion, with expectations of lower Clear Aligner volumes and ASPs due to seasonality [36][37] - For fiscal 2024, total revenue growth is expected to be 4% to 6% year-over-year, with a focus on maintaining operational efficiency and profitability [37] Other Important Information - The company repurchased approximately 0.6 million shares at an average price of $250.73, with $500 million remaining for future repurchases [35] - Cash flow from operations for Q2 was $159.8 million, with capital expenditures of $53.5 million primarily for manufacturing capacity expansion [36] Q&A Session Summary Question: Insights on guidance change and ASP dynamics - Management noted that unfavorable foreign exchange impacts and a shift in product mix to lower ASP products contributed to the guidance change, with a focus on what doctors want to buy [42][43] Question: Impact of iTero restorative scan revenue on guidance - The expected revenue from the iTero restorative launch was factored into the original guidance, and its delay contributed to the overall guidance reduction [45][46] Question: ASP decline details - The decline in ASP was attributed to a mix of lower-priced products being sold and increased utilization of the Doctor Subscription Program, which has a lower ASP but better gross margins [50][51] Question: Doctor shipping numbers and competitive landscape - Management indicated that the increase in doctor shipments reflects a growing utilization and efforts to train more doctors, despite some competitive losses [58][59] Question: Direct Fab timelines and manufacturing updates - The timeline for Direct Fab is projected to be 2 to 3 years, with significant groundwork needed before achieving full operational efficiency [62] Question: Confidence in returning to normal seasonality - Management expressed optimism about returning to more normal seasonality based on observed trends in Q2 and expectations for the upcoming quarters [66]

Align Technology (ALGN) reported $1.03 billion in revenue for the quarter ended June 2024, representing a year-over-year increase of 2.6%. EPS of $2.41 for the same period compares to $2.22 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $1.04 billion, representing a surprise of -0.89%. The company delivered an EPS surprise of +3.88%, with the consensus EPS estimate being $2.32.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and ...

align | * invisalign | iTero ©2024 Align Technology Inc. All rights reserved. 1 exocad Q2 2024 Financial Results Align Technology, Inc. July 24, 2024 Q2 2024 Conference Call Details | --- | |-------| | | | | | | | | | | | | | | | | | | | | | | | | | | Shirley Stacy, sstacy@aligntech.com Madelyn Valente, mvalente@aligntech.com ©2024 Align Technology Inc. All rights reserved. 2 Safe Harbor and Forward-Looking Statements This presentation, including the tables below, contains forward-looking statements, includ ...

Exhibit 99.1 Align Technology Announces Second Quarter 2024 Results Align Technology Zeno Group Madelyn Valente Sarah Johnson (909) 833-5839 (828) 551-4201 mvalente@aligntech.com sarah.johnson@zenogroup.com ALIGN TECHNOLOGY ANNOUNCES SECOND QUARTER 2024 FINANCIAL RESULTS Total Invisalign® patients surpasses 18 million globally, including over 5 million teens and kids Continued Hogan, "For Clear Aligners, Q2'24 volumes increased 6.2% sequentially and 3.2% year-over-year, driven by growth from adult patients, ...